COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse : Sanofi nomme Paulo Fontoura à la tête de sa R&D
22/06/2026
Sanofi nomme Paulo Fontoura à la tête de sa R&D Paris , 22 juin 2026. Sanofi annonce la nomination du Dr Paulo Fontoura au poste de Vice-Président Exécutif, Responsable mondial de la Recherche & Développement [...]
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
22/06/2026
Sanofi a ppoints Paulo Fontoura as Global Head of R&D Paris , June 22 , 2026 . Sanofi today announced the appointment of Paulo F o ntoura , MD, PhD, FAAN, as Executi v e Vice President, Global Head of Research [...]
CARBIOS présente les résultats de son Assemblée Générale du 18 juin 2026
22/06/2026
Clermont-Ferrand (France), le 22 juin 2026 (7h45 CEST). CARBIOS, (Euronext Growth Paris : ALCRB) annonce les résultats de son Assemblée Générale Ordinaire Annuelle et Extraordinaire du 18 juin 2026. Les actionnaires [...]
SKG Brings Deep Recovery Technology to Father’s Day Gifting
22/06/2026
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- This Father’s Day, SKG is bringing smart recovery to the top of the gift list with wearable smart massagers designed for dads’ everyday routines. As thoughtful gift options, [...]
Clariane has launched a proposed offering of €333 million of undated deeply subordinated hybrid notes to refinance its ODIRNANE
22/06/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane has [...]
Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
22/06/2026
First patients dosed with BI 3820768 (OB33), marking third programme from the Oxford BioTherapeutics (OBT)-Boehringer Ingelheim collaboration to enter clinical development Obrixtamig reaches late-stage development [...]
Automatisation et interopérabilité de la pharmacie hospitalière : Deenova déploiera une plateforme intégrée de gestion du médicament au Policlinico di Milano
22/06/2026
Milan, 22 juin 2026 (GLOBE NEWSWIRE) -- Deenova annonce le lancement des activités pour la réalisation du nouveau système intégré d’automatisation et de traçabilité de la gestion des médicaments au sein de la Fondazione [...]
Pharmacy automation interoperability: Deenova to deliver an integrated medication management platform at Policlinico di Milano
22/06/2026
MILAN, June 22, 2026 (GLOBE NEWSWIRE) -- Deenova announces the launch of activities for the implementation of a new integrated system for the automation and traceability of medication management at Fondazione IRCCS Ca’ [...]
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
21/06/2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with [...]
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026
Florida-distributed gummy supplement brand details current ingredients, pricing, refund policy, and customer service processes for 2026 Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026
Aurora, Colorado-based dietary supplement company refreshes publicly available product disclosures, reaffirms its 60-day money-back guarantee, and details current ordering, shipping, and support processes for 2026 [...]
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026
19/06/2026
INFORMATIONS RÉGLEMENTÉES Le 19 juin 2026, 22:30h CET / 16:30h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l' [...]
Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026
19/06/2026
SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris, MD , founder of NeuroRelief Ketamine & Infusion Therapy , has announced the availability of NAD+ IV infusion therapy as part of the clinic’s [...]
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026
CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/06/2026
SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
19/06/2026
VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its [...]
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
19/06/2026
REGULATED INFORMATION June 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026
NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Boston Dental Named The Best Dentist in Boston
19/06/2026
Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services Boston, MA, June 19, 2026 (GLOBE NEWSWIRE) -- Boston Dental, a leader in dental and aesthetic services, has [...]

Pages